Archean Chemical Industries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Archean Chemical Industries posted Q1 FY26 (quarter ended June 30, 2025) standalone revenue from operations of Rs. 278.6 crores, up about 32% year-on-year from Rs. 211.2 crores in Q1 FY25. Standalone profit after tax rose modestly to Rs. 51.8 crores (up ~7% YoY) with EPS of Rs. 4.20. On a consolidated basis, revenue grew 37% YoY to Rs. 292.4 crores, but PAT fell about 10% to Rs. 40.1 crores, weighed down by losses of roughly Rs. 10.2 crores in newly added subsidiaries and step-down entities. Sequentially, both revenue and profit dipped from a strong Q4 FY25 quarter. The auditor (PKF Sridhar & Santhanam LLP) issued an unmodified (clean) limited review conclusion on both sets of results. The company continues to deploy capital into strategic bets — silicon carbide semiconductors via Clas-SiC Wafer Fab (UK) and zinc-bromide battery technology via Offgrid Energy Labs (USA).
Strong double-digit revenue growth points to healthy demand in the core marine chemicals business, but flat standalone profits and a consolidated PAT decline suggest margin pressure and costs from ramping new subsidiaries. The diversification into semiconductors and energy storage is a long-term strategic move and may keep near-term earnings choppy, while the pending Gujarat land lease renewal remains a key watchpoint.